vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and OneStream, Inc. (OS). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $163.7M, roughly 1.7× OneStream, Inc.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 0.6%, a 95.7% gap on every dollar of revenue. On growth, OneStream, Inc. posted the faster year-over-year revenue change (23.6% vs 9.4%). Over the past eight quarters, OneStream, Inc.'s revenue compounded faster (21.8% CAGR vs 17.5%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Blue Stream provides cable television, cable telephone, DVR, and up to 1 GIG Internet speed broadband services to customers in the Florida communities of Coral Springs and Weston.
ACAD vs OS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $163.7M |
| Net Profit | $273.6M | $999.0K |
| Gross Margin | 90.8% | 69.8% |
| Operating Margin | 6.1% | -3.2% |
| Net Margin | 96.3% | 0.6% |
| Revenue YoY | 9.4% | 23.6% |
| Net Profit YoY | 90.3% | — |
| EPS (diluted) | $1.61 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $163.7M | ||
| Q3 25 | $278.6M | $154.3M | ||
| Q2 25 | $264.6M | $147.6M | ||
| Q1 25 | $244.3M | $136.3M | ||
| Q4 24 | $259.6M | $132.5M | ||
| Q3 24 | $250.4M | $129.1M | ||
| Q2 24 | $242.0M | $117.5M | ||
| Q1 24 | $205.8M | $110.3M |
| Q4 25 | $273.6M | $999.0K | ||
| Q3 25 | $71.8M | $-8.8M | ||
| Q2 25 | $26.7M | $-18.4M | ||
| Q1 25 | $19.0M | $-24.0M | ||
| Q4 24 | $143.7M | — | ||
| Q3 24 | $32.8M | $-171.9M | ||
| Q2 24 | $33.4M | $-7.8M | ||
| Q1 24 | $16.6M | $-5.0M |
| Q4 25 | 90.8% | 69.8% | ||
| Q3 25 | 92.2% | 68.1% | ||
| Q2 25 | 92.2% | 68.6% | ||
| Q1 25 | 91.7% | 68.0% | ||
| Q4 24 | 91.6% | 66.8% | ||
| Q3 24 | 92.5% | 50.1% | ||
| Q2 24 | 92.5% | 68.5% | ||
| Q1 24 | 88.8% | 69.1% |
| Q4 25 | 6.1% | -3.2% | ||
| Q3 25 | 12.8% | -11.3% | ||
| Q2 25 | 12.2% | -21.8% | ||
| Q1 25 | 7.9% | -29.3% | ||
| Q4 24 | 59.1% | -35.8% | ||
| Q3 24 | 12.6% | -197.6% | ||
| Q2 24 | 12.6% | -9.8% | ||
| Q1 24 | 7.4% | -4.9% |
| Q4 25 | 96.3% | 0.6% | ||
| Q3 25 | 25.8% | -5.7% | ||
| Q2 25 | 10.1% | -12.5% | ||
| Q1 25 | 7.8% | -17.6% | ||
| Q4 24 | 55.4% | — | ||
| Q3 24 | 13.1% | -133.1% | ||
| Q2 24 | 13.8% | -6.7% | ||
| Q1 24 | 8.0% | -4.5% |
| Q4 25 | $1.61 | — | ||
| Q3 25 | $0.42 | — | ||
| Q2 25 | $0.16 | — | ||
| Q1 25 | $0.11 | — | ||
| Q4 24 | $0.86 | — | ||
| Q3 24 | $0.20 | $-1.06 | ||
| Q2 24 | $0.20 | — | ||
| Q1 24 | $0.10 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $693.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $504.7M |
| Total Assets | $1.6B | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $693.6M | ||
| Q3 25 | $258.0M | $653.9M | ||
| Q2 25 | $253.6M | $652.1M | ||
| Q1 25 | $217.7M | $593.9M | ||
| Q4 24 | $319.6M | $544.2M | ||
| Q3 24 | $155.1M | $495.5M | ||
| Q2 24 | $177.1M | $140.5M | ||
| Q1 24 | $204.7M | — |
| Q4 25 | $1.2B | $504.7M | ||
| Q3 25 | $917.3M | $472.1M | ||
| Q2 25 | $822.4M | $458.2M | ||
| Q1 25 | $765.2M | $412.9M | ||
| Q4 24 | $732.8M | $386.2M | ||
| Q3 24 | $577.2M | $458.2M | ||
| Q2 24 | $516.7M | $97.5M | ||
| Q1 24 | $464.0M | $102.5M |
| Q4 25 | $1.6B | $1.0B | ||
| Q3 25 | $1.3B | $949.4M | ||
| Q2 25 | $1.2B | $910.5M | ||
| Q1 25 | $1.1B | $867.3M | ||
| Q4 24 | $1.2B | $823.2M | ||
| Q3 24 | $976.9M | $750.1M | ||
| Q2 24 | $914.1M | $379.7M | ||
| Q1 24 | $855.1M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $25.8M |
| Free Cash FlowOCF − Capex | — | $25.6M |
| FCF MarginFCF / Revenue | — | 15.7% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | -0.18× | 25.79× |
| TTM Free Cash FlowTrailing 4 quarters | — | $95.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $25.8M | ||
| Q3 25 | $74.3M | $5.0M | ||
| Q2 25 | $64.0M | $29.7M | ||
| Q1 25 | $20.3M | $36.2M | ||
| Q4 24 | $40.4M | — | ||
| Q3 24 | $63.2M | $2.4M | ||
| Q2 24 | $25.0M | $8.1M | ||
| Q1 24 | $29.1M | $25.5M |
| Q4 25 | — | $25.6M | ||
| Q3 25 | $73.9M | $4.8M | ||
| Q2 25 | — | $29.4M | ||
| Q1 25 | — | $35.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | $63.2M | $1.3M | ||
| Q2 24 | — | $7.7M | ||
| Q1 24 | — | $24.9M |
| Q4 25 | — | 15.7% | ||
| Q3 25 | 26.5% | 3.1% | ||
| Q2 25 | — | 19.9% | ||
| Q1 25 | — | 26.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | 1.0% | ||
| Q2 24 | — | 6.6% | ||
| Q1 24 | — | 22.5% |
| Q4 25 | — | 0.1% | ||
| Q3 25 | 0.1% | 0.1% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | 0.8% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | -0.18× | 25.79× | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 2.40× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | — | ||
| Q2 24 | 0.75× | — | ||
| Q1 24 | 1.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
OS
| Subscription And Circulation | $150.3M | 92% |
| Professional Services And Other | $9.4M | 6% |
| License | $4.0M | 2% |
